Volgen
David R. Langley
David R. Langley
Executive Director Platform Chemistry, Arvinas Inc.
Geverifieerd e-mailadres voor arvinas.com
Titel
Geciteerd door
Geciteerd door
Jaar
PROTAC targeted protein degraders: the past is prologue
M Békés, DR Langley, CM Crews
Nature reviews Drug discovery 21 (3), 181-200, 2022
18422022
Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect
M Gao, RE Nettles, M Belema, LB Snyder, VN Nguyen, RA Fridell, ...
Nature 465 (7294), 96-100, 2010
11412010
Selective interactions of cationic porphyrins with G-quadruplex structures
H Han, DR Langley, A Rangan, LH Hurley
Journal of the American Chemical Society 123 (37), 8902-8913, 2001
4352001
Inhibition of hepatitis B virus polymerase by entecavir
DR Langley, AW Walsh, CJ Baldick, BJ Eggers, RE Rose, SM Levine, ...
Journal of virology 81 (8), 3992-4001, 2007
2402007
Biochemical and genetic characterizations of a novel human immunodeficiency virus type 1 inhibitor that blocks gp120-CD4 interactions
Q Guo, HT Ho, I Dicker, L Fan, N Zhou, J Friborg, T Wang, BV McAuliffe, ...
Journal of virology 77 (19), 10528-10536, 2003
2252003
Pyrrolo [1, 4] benzodiazepine antitumor antibiotics: relationship of DNA alkylation and sequence specificity to the biological activity of natural and synthetic compounds
LH Hurley, T Reck, DE Thurston, DR Langley, KG Holden, RP Hertzberg, ...
Chemical research in toxicology 1 (5), 258-268, 1988
2141988
Geen titel
WO Patent 2008021927:A2, 0
188*
A versatile and efficient synthesis of carbinolamine-containing pyrrolo [1, 4] benzodiazepines via the cyclization of N-(2-aminobenzoyl) pyrrolidine-2-carboxaldehyde diethyl …
DR Langley, DE Thurston
The Journal of Organic Chemistry 52 (1), 91-97, 1987
1851987
Compounds useful as immunomodulators
LS Chupak, X Zheng
1592015
Macrocyclic inhibitors of the PD-1/PD-L1 and CD80 (B7-1)/PD-L1 protein/protein interactions
MM Miller, C Mapelli, MP Allen, MS Bowsher, KM Boy, EP Gillis, ...
US Patent 9,308,236, 2016
1572016
Inhibitors of HIV-1 attachment: the discovery and development of temsavir and its prodrug fostemsavir
NA Meanwell, MR Krystal, B Nowicka-Sans, DR Langley, DA Conlon, ...
Journal of medicinal chemistry 61 (1), 62-80, 2018
1472018
Inhibition of influenza virus replication via small molecules that induce the formation of higher-order nucleoprotein oligomers
SW Gerritz, C Cianci, S Kim, BC Pearce, C Deminie, L Discotto, ...
Proceedings of the National Academy of Sciences 108 (37), 15366-15371, 2011
1452011
Crystal structures of trimeric HIV envelope with entry inhibitors BMS-378806 and BMS-626529
M Pancera, YT Lai, T Bylund, A Druz, S Narpala, S O'Dell, A Schön, ...
Nature chemical biology 13 (10), 1115-1122, 2017
1442017
Chemistry and structure elucidation of the kedarcidin chromophore
JE Leet, DR Schroeder, DR Langley, KL Colson, S Huang, SE Klohr, ...
Journal of the American Chemical Society 115 (18), 8432-8443, 1993
1421993
Molecular dynamic simulations of environment and sequence dependent DNA conformations: the development of the BMS nucleic acid force field and comparison with experimental results
DR Langley
Journal of Biomolecular Structure and Dynamics 16 (3), 487-509, 1998
1401998
A general amino acid synthesis enabled by innate radical cross‐coupling
S Ni, AF Garrido‐Castro, RR Merchant, JN de Gruyter, DC Schmitt, ...
Angewandte Chemie 130 (44), 14768-14773, 2018
1392018
Targeting a binding pocket within the trimer-of-hairpins: small-molecule inhibition of viral fusion
C Cianci, DR Langley, DD Dischino, Y Sun, KL Yu, A Stanley, J Roach, ...
Proceedings of the National Academy of Sciences 101 (42), 15046-15051, 2004
1282004
The crystal structure of NS5A domain 1 from genotype 1a reveals new clues to the mechanism of action for dimeric HCV inhibitors
SM Lambert, DR Langley, JA Garnett, R Angell, K Hedgethorne, ...
Protein Science 23 (6), 723-734, 2014
1192014
Discovery of a 2,4-Disubstituted Pyrrolo[1,2-f][1,2,4]triazine Inhibitor (BMS-754807) of Insulin-like Growth Factor Receptor (IGF-1R) Kinase in Clinical Development
MD Wittman, JM Carboni, Z Yang, FY Lee, M Antman, R Attar, P Balimane, ...
Journal of medicinal chemistry 52 (23), 7360-7363, 2009
1182009
Discovery of new acylaminopyridines as GSK-3 inhibitors by a structure guided in-depth exploration of chemical space around a pyrrolopyridinone core
P Sivaprakasam, X Han, RL Civiello, S Jacutin-Porte, K Kish, M Pokross, ...
Bioorganic & medicinal chemistry letters 25 (9), 1856-1863, 2015
1142015
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20